Matrix-Enhanced Antagonism of Milk-Derived Lactobacillus acidophilus Supernatant Against Biofilm-Forming, Multidrug-Resistant Klebsiella oxytoca from Dairy and Pediatric Samples
Pathogens · 22.10.2026 · 15 (11) · 1104
DOI: 10.3390/pathogens15111104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 22.10.2026. Verfasst von Azza SalahEldin El-Demerdash und 10 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Klebsiella oxytoca is an emerging opportunistic pathogen capable of causing bovine mastitis and neonatal colonization. This study provides a comprehensive molecular and phenotypic characterization of K. oxytoca across dairy supply nodes and pediatric host matrices while evaluating a probiotic-based bio-intervention strategy. K. oxytoca was isolated from 27.9% (39/140) of examined samples across dairy supply nodes and infant stool in Egypt, with equal peak prevalence in clinical mastitic milk (40.0%, 8/20) and infant fecal specimens (40.0%, 8/20). High rates of multidrug resistance (MDR; 66.7%, 26/39) were observed, with all isolates (100%) confirmed as extended-spectrum β-lactamase (ESBL) producers. Colistin (CT) and azithromycin resistance reached 46.2% (18/39) overall, peaking in commercial milk (69.2% for CT). Molecular screening revealed high frequencies of the mobile colistin resistance gene mcr-1 (41.0%, 16/39) and the ESBL determinant blaCTX-M (66.7%, 26/39), alongside fimbrial adhesion (mrkA, 76.9%) and iron acquisition (kfuBC, 82.1%) loci. All isolates (100%) exhibited strong biofilm-forming capacity (mean OD570 = 0.63 ± 0.016), while toxin-antitoxin (TA) modules (symE, ccdB, relE) correlated positively with MDR profiles (p = 0.024). Bacterial virulence gene burden showed strong statistical associations with host tissue damage and inflammatory markers, including elevated milk lactate dehydrogenase (LDH; r = 0.918), haptoglobin (r = 0.954), and neonatal fecal calprotectin (FC; 83.34 ± 21.13 μg/g vs. 22.4 ± 2.0 μg/g in controls, p = 0.02). Crucially, milk-based cell-free metabolic supernatant (CFS) from Lactobacillus acidophilus demonstrated superior antagonistic activity compared to broth-based CFS (inhibition zones up to 40 mm vs. 12 mm against CT-resistant isolates). In silico molecular docking predicted strong binding affinities of putative L. acidophilus bioactive peptides (Acidocin 8912 score: −108.07 kcal/mol; Acidocin B score: 80.63 kcal/mol) to K. oxytoca outer membrane porin CymA and transport targets. These findings highlight the co-occurrence of resilient K. oxytoca lineages across food and pediatric matrices and demonstrate the therapeutic potential of probiotic-derived CFS as a non-antibiotic control strategy within a One Health framework.
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
El-Demerdash, A. S., Sonbol, H., Saleh, A. M., Sakr, E., Samir, M., Elaadli, H., Abd-Elfatah, E. B., Mahmoud, Y. K., Eid, S., El-Malt, R. M. S., & ElDaly, R. A. (2026). Matrix-Enhanced Antagonism of Milk-Derived Lactobacillus acidophilus Supernatant Against Biofilm-Forming, Multidrug-Resistant Klebsiella oxytoca from Dairy and Pediatric Samples. Pathogens, 15(11), 1104. https://doi.org/10.3390/pathogens15111104
Vancouver
El-Demerdash AS, Sonbol H, Saleh AM, Sakr E, Samir M, Elaadli H, et al. Matrix-Enhanced Antagonism of Milk-Derived Lactobacillus acidophilus Supernatant Against Biofilm-Forming, Multidrug-Resistant Klebsiella oxytoca from Dairy and Pediatric Samples. Pathogens. 2026;15(11):1104. doi:10.3390/pathogens15111104
BibTeX
@article{ElDemerdash2026,
author = {El-Demerdash, Azza SalahEldin and Sonbol, Hana and Saleh, Abdulrahman M. and Sakr, Emad and Samir, Mohamed and Elaadli, Haitham and Abd-Elfatah, Eman Beshry and Mahmoud, Yasmina K. and Eid, Samah and El-Malt, Rania M. S. and ElDaly, Rania A.},
title = {Matrix-Enhanced Antagonism of Milk-Derived Lactobacillus acidophilus Supernatant Against Biofilm-Forming, Multidrug-Resistant Klebsiella oxytoca from Dairy and Pediatric Samples},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {11},
pages = {1104},
doi = {10.3390/pathogens15111104}
}
EUVIMED